Premium
Monensin controlled‐release intraruminal capsule for control of bloat in pastured dairy cows
Author(s) -
LOWE LB,
BALL GJ,
CARRUTHERS VR,
DOBOS RC,
LYNCH GA,
MOATE PJ,
POOLE PR,
VALENTINE SC
Publication year - 1991
Publication title -
australian veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.382
H-Index - 59
eISSN - 1751-0813
pISSN - 0005-0423
DOI - 10.1111/j.1751-0813.1991.tb09834.x
Subject(s) - monensin , pasture , rumen , biology , zoology , grazing , dairy cattle , lactation , agronomy , food science , fermentation , pregnancy , genetics
SUMMARY Monensin, a polyether ionophore antibiotic, is potentially an important agent for bloat relief in dairy cows grazing temperate legume‐based pasture. A series of studies was undertaken to determine the effect of monensin, when delivered continuously in the rumen of lactating dairy cows by means of controlled‐release capsules (monensin CRC). Such devices release approximately 300 mg/head/day for 100 d. A short‐term pilot study made at Ruakura, New Zealand, tested monensin CRC in cows selected for high susceptibility to bloat and grazing lucerne ( Medicago sativa ) or red clover ( Trifolium pratense ). Treatment significantly reduced the incidence of bloat, while milk yield and protein yield were increased. There was no effect on fat yield.Following the pilot study, 6 large‐scale field experiments involving a total of 368 lactating dairy cows, were made in Australia and New Zealand to confirm the effectiveness of monensin CRC for bloat control and to measure the effect of such treatment on milk production and composition. A severe bloat problem occurred in 2 experiments, mild bloat occurred in 2 others, while no visual signs of bloat were observed in the remaining 2 experiments. Bloat was significantly (P < 0.05) reduced by monensin CRC treatment when data was pooled over the 4 experiments in which bloat occurred. Daily milk yield was increased in all experiments from a mean of 17.7 in untreated groups to 18.8 kg/head/day (P < 0.05) in monensin CRC‐treated cows. Protein percentage was not affected by treatment, while there was a decrease from 4.29 to 4.10% fat, although total fat yield was not affected. No monensin residues were detected in serial samples of milk taken from 2 of the field experiments using an assay with a sensitivity of method of less than 2.5 ng/ml. Treatment of dairy cows grazing temperate legume pastures with monensin CRC reduced the severity of bloat and increased milk production, which could lead to the commercial use of the product on Australian and New Zealand dairy farms.